Stay updated on Daratumumab & DLI for Relapsed AML Clinical Trial
Sign up to get notified when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.
Latest updates to the Daratumumab & DLI for Relapsed AML Clinical Trial page
- Check6 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.4%
- Check13 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedSeveral links related to leukemia, organ donation, and stem cells have been removed, indicating a significant reduction in available resources on these topics.SummaryDifference4%
- Check35 days agoChange DetectedNew resources have been added related to leukemia, organ donation, and stem cells, including links to MedlinePlus and NIH, which may be of particular interest to users seeking information on these topics.SummaryDifference1%
- Check42 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading study data in various formats and displaying detailed participant and study information, while removing the option to show less content.SummaryDifference5%
- Check50 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.7%
Stay in the know with updates to Daratumumab & DLI for Relapsed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.